Price $71.98 |
Market Cap
6.75B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.4
|
P/B
2.25
|
P/S
2.37
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
158.1
|
Op. Cash Flow
362.8K
|
FCF
0.4
|
|
Op. Margin
16.00%
|
Net Margin
9.70%
|
ROE
9.60%
|
ROI
8.30%
|
|
ROA
5.40%
|
EPS Growth
-3.50%
|
Current Ratio
1.3
|
Debt/Equity
48.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc (COLL) | $27.18 | - | - | 752M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $21.63 | - | - | 1.19B | Strong Buy |
| Marizyme Inc (MRZM) | $0.12 | - | - | 8.6M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.42 | - | - | 14.8M | Strong Buy |
| Omnicell Inc (OMCL) | $35.15 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
